SCHEMBL19246582

SCHEMBL19246582

c1ccc(-c2nc(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)nc3sc4ccccc4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.33
▸ PDE1B Q01064 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ PDE11A Q9HCR9 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ MAPT P10636 2/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ HTT P42858 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ ADORA2B P29275 1/20 0.30
▸ ADORA1 P30542 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18961945 0.91 KDM4E (0.31) KDM4EALDH1A1MAPTHPGDNPSR1
SCHEMBL19246658 0.91 KDM4E (0.34) L3MBTL1KDM4EATM
SCHEMBL19246342 0.91 KDM4E (0.37) L3MBTL1KDM4EATM
SCHEMBL18674879 0.90 KDM4E (0.38) L3MBTL1KDM4EATMHSD17B10PDE1B
SCHEMBL19246503 0.90 L3MBTL1 (0.40) L3MBTL1KDM4EATMHSD17B10PDE1B
SCHEMBL16905742 0.89 KDM4E (0.35) L3MBTL1KDM4EATMHSD17B10KMT2A
SCHEMBL18962062 0.89 — —
SCHEMBL19246417 0.89 L3MBTL1 (0.39) L3MBTL1KDM4EATMHSD17B10PDE1B
SCHEMBL22199936 0.89 L3MBTL1 (0.35) L3MBTL1KDM4EATMHSD17B10PDE1B
SCHEMBL16905628 0.88 KDM4E (0.40) L3MBTL1KDM4EATMHSD17B10PDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 L3MBTL1 470/4885KDM4E 4143/4885ATM 638/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 L3MBTL1 470/4885KDM4E 4143/4885ATM 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback